BioCentury
ARTICLE | Company News

Enterome Bioscience, J&J, INRA deal

January 11, 2016 8:00 AM UTC

Enterome, Johnson & Johnson’s Janssen Biotech Inc. subsidiary and INRA partnered to discover targets and bioactive molecules from the gut microbiome to treat Crohn’s disease. Enterome is eligible for an undisclosed upfront payment plus undisclosed R&D funding from Janssen. Janssen has an option to gain an exclusive license to develop and commercialize resulting candidates. ...